| 04/23/2008 | Jamie
Li, Ph.D., Director, Urology/Gynecology R/D
Boston Scientific The Practical Part of Biotechnology |
| 04/16/2008 | Michael
A. Davitz, M.D., J.D., Partner Axinn, Veltrop & Harkrider LLP The Role of Intellectual Property in the Pharmaceutical and Biotechnology Environment |
| 04/09/2008 | Aseem Anand,
Biotech Alumnus Clinical Trial Coordinator, MSKCC, and Founder, BioTrak Organizational Issues in Biotech |
| 04/02/2008 | David
Best, M.D., M.B.A., President, and Michael Banks, M.D., Vice President MDea, Inc. Careers in Medical Communication and Big Pharma |
| 03/26/2008 | Alan
E. Smith, Ph.D., Senior Vice President, Research, Chief Scientific
Officer Genzyme Corp Therapies for Genetic Diseases |
| 03/12/2008 | David
Sable, M.D., Fund Manager Special Situations Life Sciences Fund Investing in Biotechnology: Inside a Life Sciences Hedge Fund |
| 03/05/2008 | Michael
Rice, Senior Consultant Defined Health Cardiovascular Franchises: Too Much Risk in Prevention? |
| 02/27/2008 | Greg Homison, Ph.D. Director of Research and Technical
Services Department of Biological Sciences Infrastructure: From the Mechanical to the Interpersonal |
| 02/20/2008 | Angelos M. Stergiou, M.D. VP Product Development,
Medical Affairs & Clinical Research Accentia Biopharmaceuticals Treating and Curing Patients, Clinical Research and Development |
| 02/13/2008 | Daijin Kim, M.B.A., Associate
Director, Healthcare
Informatics Pfizer Human Health Challenges & Opportunities in the Pharmaceutical Industry |
| 04/25/2007 | Ross
Grossman, Ph.D., M.B.A., VP,
Human Resources Regeneron Pharmaceuticals, Inc. Organizational Issues in Biotech |
| 04/11/2007 | Ivica Labuda, Founder and President Biokeys for Flavors, LLC Biotechnology Role in Flavor Industry |
| 04/04/2007 | Kelly
Wines, Associate Fitzpatrick, Cella, Harper & Scinto Intellectual Property: Where Technology Meets the Law |
| 03/28/2007 | Jerry
Di Salvo, Distinguished
Senior Research Associate, Department of Immunology Merck Research Laboratories A View from the Bench: Basic Research and Drug Development |
| 03/21/2007 | Melanie Rolli, M.D., Director,
Brand Safety LeaderIntegrated
Medical Safety, Novartis Pharmaceuticals Corporation From Bench to Bedside: The Process and the People that Turn an Idea into a Drug |
| 03/07/2007 | Vivien
Marx, Science Writer Science Writing The Art of Describing Science to the World |
| 02/28/2007 | Chau Cheng, Ph.D., Associate
Director, Investor Relations and Business Analysis Immunomedics Investor Relations in the Biotech sector. What is unique about it? |
| 02/14/2007 | Nelson Scharadin, Investment Banker Healthcare Investment Banking, Oppenheimer & CoFalling forward in the business of Biotechnology |
| 02/07/2007 | Heather
Butts, Regulatory
Specialist, Institutional Review
Board,
ColumbiaUniversity Bringing it all together: issues in research ethics, history and review |
| 04/26/2006 | Gary Shangold,
M.D.President & Managing MemberConvivotech, LLC. Creating Your Own Career in the Life Sciences |
| 04/19/2006 | Ron Guido and Alan McEmber, Directors, Worldwide Regulatory Strategy Pfizer Pitfall Avoidance: Regulatory Affairs as Tactician in Biotechnology Product Development |
| 04/05/2006 | Eugene Trogan,
Ph.D. Biotechnology
Analyst Ursus Capital Management Biotech and the Savvy Investor: How to Stay with the Good and part with the Bad |
| 03/29/2006 | Thierry Teil,
M.D. Executive Director The Medicines Company Pharma and Biotech Industry: Overview & Opportunities for Biology Graduates |
| 03/22/2006 | Steve Dinh, Sc.D. Vice
President, Research and Technology Development Emisphere Oral Delivery of Protein Therapeutic Molecules |
| 03/08/2006 | Eliene Augenbraun,
D.O., Ph.D. CEO and President ScienCentral, Inc. Bite Size Biotech – how most Americans learn about science |
| 03/01/2006 | Philip Braginsky,
J.D. Of
Counsel Sills Cummis Epstein and Gross The Commercial Realm of Patents |
| 02/15/2006 | Holly Hilton, Ph.D. Research Informatics,
Genetics and Genomics Hoffmann-La Roche Inc. The Role of Functional Genomics in Drug Discovery |
| 02/10/2006 | Marie Teil,
M.D. Director, Clinical Trials Office Mount Sinai School of Medicine Drug Approval Process -from an FDA perspective or from a pharma point of view |
| 02/08/2006 | Jeff Yablon, Principal Yablon Management Consulting/PharmaScan Clinical Trials, LLC. Introduction to Clinical Development & Biotech Management Concepts |
| 02/01/2006 | Lata Jayaraman,
Ph.D. Senior
Research Investigator Bristol-Myers Squibb Choosing a Career in the Bio-Pharmaceutical Industry |
| 04/27/2005 | William Fair, M.A. VP, Healthcare &
Biosciences Commercial Bioscience in |
| 04/20/2005 | Josh Xiao, Ph.D. Sr. Scientist Amgen San Francisco High Throughput Screening in the Functional Genomics Era |
| 04/13/2005 | Ivan Oransky, M.D. Deputy Editor The Scientist Biotechnology and the Media |
| 04/06/2005 | Costa Papastephanou, Ph.D. President and
COO Ortec International The Anatomy of a Biotech Company |
| 03/30/2005 | Linda Armstrong, M.D. Medical Director Pfizer Assessing Drug Safety: From Bench to Blockbuster |
| 03/23/2005 | Mark Kay, M.D., Ph.D. Director,
Human
Gene
Therapy
Program StanfordUniversity Gene Transfer Strategies for Treating Hemophilia and Viral Hepatitis |
| 03/09/2005 | Allen Fienberg, Ph.D. Founder & VP,
Business Development Intra-Cellular Therapies Reflections on the Transition from Academia to Corporate Life |
| 03/02/2005 | Michael Yamin,
Ph.D. Director,
Technology Development Warren Pharmaceuticals, Inc. Tissue Protective Cytokines from Discovery to Development |
| 02/23/2005 | Jeff Margolis, President Aurora Capital LLC Start-up and Early Stage Biotechnology Companies: Translating Science into Products |
| 02/16/2005 | Charles Ryan, Ph.D., J.D. Executive Director, Chief Patent
Counsel Forest Laboratories, Inc. The Role of Intellectual Property in Pharmaceutical Drug Development |
| 04/21/2004 | Eelco A. Slagter,
M.S. Director
of Science and Technology AMDeC foundation, inc. Developments in the Biosciences: An Integrative Approach |
| 04/14/2004 | Ramana Sonty,
MBBS, Ph.D. Senior
Director, Worldwide Development Pfizer Integrated R&D/Commercial Cross-Functional Approaches to Strategy, Portfolio and Risk |
| 04/07/2004 | Rene Baston,
M.A. and Matthew McCooe,
M.B.A., Associate
Directors ColumbiaUniversity Science and Technology Ventures Technology Transfer - Making an Impact |
| 03/31/2004 | Sundeep Bhan, President and CEO Medsite, Inc. Exploring Entrepreneurial Opportunities in Biotechnology |
| 03/24/2004 | Nicholas Giorgio, Ph.D. Senior Director of Protein
Sciences ImClone Systems, Inc. A Brief History of Erbitux, from the Lab Bench to Aapproval and Beyond |
| 03/10/2004 | Melanie Rolli,
M.D. Associate
Director, Clinical Research Novartis Pharmaceuticals From Bench to Bedside: The Process and the People that Turn an Idea into a Drug |
| 03/03/2004 | Mary Morry,
Ph.D., J.D. Senior
Attorney, Intellectual Property Litigation Merck & Co. Patents and Practical Tips for Obtaining and Using Them |
| 02/25/2004 | Ilya Trakht,
D. Sc. Chief
Research Consultant Acceptys Totally Human Antibodies: from Bench Science to Biotech Business |
| 02/11/2004 | David Sudolsky,
M.B.A. Principal Sudco Consulting Adventures of a Serial Biotech Entrepreneur |
| 02/04/2004 | David Weinstein, Ph.D., M.D. President and Chief Scientific
Officer GliaMed Inc. Biology-based Drug Discovery in the Nervous System |
| 01/28/2004 | Charles Jennings, Ph.D. Executive Editor Nature Research Journals The Role of Journals in the Communication of Science |
| 04/23/2003 | Louis J. Capezzuto,
J.D. M.A.Patent Law Department Johnson & Johnson Biotechnology Patents 101- The Basics |
| 04/16/2003 | Uwe Scherf,
Ph.D. Director,
R
& D Gene Logic Whole Genome Expression Profiling: Generating and Utilizing High Quality Data |
| 04/09/2003 | Nezih Cereb,
M.D. Executive VP and co-founder Histogenetics, Inc. Clinical Implications of Polymorphism of the Human MHC (Major Histocompatibilty Complex) Genes--Industrialization of Molecular Tissue Typing |
| 04/02/2003 | Don O’Sullivan, Ph.D. Senior Account
Executive Euro RSCG Life NRP Communicating Biotechnology-the value of public and investor relations in the life sciences industry |
| 03/26/2003 | Rene Baston,
M.A. and Matthew McCooe,
M.B.A.,
Associate Directors ColumbiaUniversity Science and Technology Ventures Technology Transfer from Academia |
| 03/12/2003 | Tina Lopingo,
Ph.D. Director,
Technology and Business Development New York Biotechnology Association |
| 03/05/2003 | Julie Kan, Ph.D. Senior Research Investigator OSI Pharmaceuticals The ‘omics’ World for Small Molecule Cancer Drug Discovery |
| 02/26/2003 | Bharat Mehta, Ph.D. VP Manufacturing Operations Genta, Inc. Regulatory Requirements in Pharmaceutical Manufacturing with Focus on Critical Utilities and BSE/TSE-Viral Safety |
| 02/19/2003 | Andrew Marshall, Ph.D. Editor Nature Biotechnology The Vision of Genomics and the Reality in Drug Development |
| 02/12/2003 | Timothy Howe, M.B.A. Partner Collinson Howe &Lennox Medical Partners Venture Capital in the Biotechnology Space |
| 02/05/2003 | Rudolph Spangler,
Ph.D.
Senior
Research
Associate RockefellerUniversity Designing an Efficient High Throughput Gene Expression Technology |
| 01/29/2003 | M. Timothy Cooke, Ph.D. M.B.A. CEO Mojave Therapeutics Creating Value: Business Models in Biotechnology |
| 05/01/2002 | Anthony J. Russo, Ph.D. CEO and General Manager Noonan/ Russo Public Relationship in Biotechnology |
| 04/24/2002 | Hillel Cohen, Ph.D. Director, Drug Regulatory Affairs Novartis Pharmaceutical Corporation The Role of Regulatory Affairs in Development of Biopharmaceuticals. |
| 04/17/2002 | Kenneth H. Sonnenfeld,
Ph.D. Partner Morgan and Finnegan The Swinging Pendulum of Biotechnology Patent Law: What’s patenable and What’s Not |
| 04/10/2002 | Robert Crowl,
Ph.D. Novartis Pharmaceuticals Corporation Genomics and Drug Target Discovery Facing the Challenge of Osteoarthritis |
| 04/03/2002 | Frank Carrigan,
Ph.D. Beth S. Kauderer, Ph D., J.D. Mathew McCooe, M.B.A. Director
and
Associate
Directors ColumbiaUniversity Science and Technology Ventures Risk in the Capital Transformation Process |
| 03/27/2002 | George D. Yancopoulos,
M.D. Ph.D. President,
Executive VP and CSO Regeneron Pharmaceuticals Merging Biology with Drug Discovery in Obesity, Inflammation, Angiogenesis, Muscle Disease & Other Setting |
| 03/13/2002 | OSI Pharmaceuticals Field trip |
| 03/06/2002 | Young
WhanPark, Ph.D. Research Fellow Merck Research Laboratories Current Techniques in High Throughput Screening for Drug Discovery Processes |
| 02/27/2002 | Jean Denaro,
M.A. Project
Manager Pfizer Pharmaceuticals Clinical Research: Methods and Opportunities |
| 02/20/2002 | Harmen Bussemaker,
Ph.D. Professor ColumbiaUniversity Computational Analysis of Genome Sequences and DNA Microarray Data |
| 02/13/2002 | Alex Elbrecht,
Ph.D. Research
Fellow Merck Research Laboratories Compound Characterization Using Gene Microarrays |
| 02/06/2002 | Ron Cohen, M.D. President, CEO, Founder and
Director Acorda Therapeutics So You Want to Start a Biotech Company, Hmmm? |
| 11/28/2001 | Jules T. Mitchel,
Ph.D. President Target Health, Inc. Principles of Drug Development: a case study in AIDS |
| 11/19/2001 | Raymond S. Fersko,
J.D. Mints, Levin, Cohn, Ferris, Glowsky & Pepeo, P.C. Commercializing Biotechnology |
| 10/01/2001 | Meirav Chovav,
M.A. M.B.A. Managing
Director Credit Suisse First Boston Biotech, A Business Built on Science |
| 04/25/2001 | Shubha Govind,
Ph.D. Professor City University of New York, Drug Development Using Flies and Model Organisms |
| 04/18/2001 | Conrad Gilliam, Ph.D. Professor Columbia GenomeCenter Identification of Genetic Loci of Human Diseases |
| 04/11/2001 | Bernie Yurke,
Ph.D. Lucent Technologies Assembling Nanostructures and Nanomotors out of DNA |
| 04/04/2001 | Rene Hen, Ph.D. Professor Columbia University Department of Pharmacology Animal Models for Diseases |
| 03/28/2001 | Robert Pearlman, Esq. Intellectual Property Causes Patenting |
| 03/21/2001 | Stuart Fischer,
Ph.D.Research
Scientist Columbia GenomeCenter High Through-put Physical Mapping |
| 03/07/2001 | Juergen Hammer, Ph.D. Hoffmann-La Roche Inc. Gene Chips and Applications |
| 02/28/2001 | Victor
Lin
,
Ph.D. ColumbiaUniversity Irvin CancerCenter Transgenic Mice Facilities |
| 02/21/2001 | James Russo, Ph.D. Research Scientist Columbia University Columbia Genome Center The Human Genome Project, Genome Sequencing, and Disease Gene Discovery |
| 02/14/2001 | Chris Adams, Founder and President Mosaic Technologies Entrepreneurship in Biotech Industry |
| 02/07/2001 | Eric Schon,
Ph.D. Professor Columbia University Department of Genetics and Development Molecular Genetics of Human Mitochondrial Disease |
| 01/31/2001 | Cy Stein, M.D. Professor Columbia University Department of Medicine Theory and Practice of the Antisense Biotechnology |
| 01/24/2001 | Donald Landry, M.D. Professor Columbia University Department of Medicine Anti-cocaine Catalytic Antibodies |
| 01/17/2001 | Arthur Bank, M.D. Professor Columbia University Department of Medicine On the Road to Hematopoietic Stem Cell Gene therapy |